China Plans Law Revisions To Encourage Orphan, Pediatric Drug Development
Ethics Review Changes Also
New draft rules outline market exclusivity provisions for orphan and pediatric drug development, along with mutual recognition of ethics reviews, in developments being seen as positive for the industry.
